deltatrials
Terminated PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT06462820

SAINT for MDD in an Inpatient Setting Follow-on

SAINT® Neuromodulation System for the Treatment of Depression in an Inpatient Setting

Sponsor: Magnus Medical

Updated 4 times since 2024 Last updated: Mar 19, 2025 Started: Jun 30, 2024 Primary completion: Mar 6, 2025 Completion: Mar 6, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Funding discontinued.

Other terminated trials from Magnus Medical

More terminations from Magnus Medical

A PHASE2/PHASE3 clinical study on Major Depressive Disorder and Major Depressive Episode, this trial is terminated or withdrawn. The trial is conducted by Magnus Medical and has accumulated 4 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotNot Yet Recruiting~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshotRecruiting~Nov 2024 – ~Apr 2025 · 5 months · monthly snapshotRecruiting~Apr 2025 – present · 15 months · monthly snapshotTerminated

Change History

4 versions recorded
  1. Apr 2025 — Present [monthly]

    Terminated PHASE2/PHASE3

    Status: RecruitingTerminated

  2. Nov 2024 — Apr 2025 [monthly]

    Recruiting PHASE2/PHASE3

  3. Sep 2024 — Nov 2024 [monthly]

    Recruiting PHASE2/PHASE3

    Status: Not Yet RecruitingRecruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting PHASE2/PHASE3

    First recorded

Jun 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Magnus Medical
Data source: Magnus Medical

For direct contact, visit the study record on ClinicalTrials.gov .